MED News and Press, MEDIFAST INC From 12/13/23

Health and wellness company makes $20 million capital commitment to LifeMD, enters medically supported weight loss market projected to reach up to $100 billion by 2030 Company discontinues quarterly cash dividend and intends to invest in initiatives aimed at driving customer acquisition a...

2023-11-24 05:46:27 ET Summary Medifast has strong financials with a healthy cash position and no debt, but its sales have plummeted, and its business model is questionable. MED's efficiency and profitability metrics are impressive, but its high-priced products may deter customers...

2023-11-19 10:14:12 ET Summary Dividend growth stocks often provide reliable cash flows and long-term wealth for income investors. Screening dividend stocks based on safety, growth, and consistency can be beneficial to find new opportunities important for investors. In this mo...

2023-11-18 08:00:00 ET Summary The consumer staples sector is very close to 11-year averages in valuation. The tobacco industry has the best value score, but quality metrics are underwhelming. iShares US Consumer Staples ETF has been outperforming XLP since inception. ...

2023-11-09 08:40:22 ET Summary Medifast, Inc. stock is down 80% from its mid-2021 peak, and from a valuation perspective, it looks like a veritable deep-value opportunity. Medifast is currently facing challenges due to elevated consumer price inflation, but increasingly also due t...

2023-11-06 18:50:27 ET Medifast, Inc. (MED) Q3 2023 Earnings Conference Call November 06, 2023, 04:30 PM ET Company Participants Steven Zenker - Vice President of Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Of...

2023-11-06 16:07:28 ET More on Medifast Medifast: The Race To Weight-Loss Drugs Not Lost Yet Seeking Alpha’s Quant Rating on Medifast Historical earnings data for Medifast Dividend scorecard for Medifast Financial information for Medifast ...

Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA® , today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 Revenue of $235.9 million, with revenue per activ...

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

MEDIFAST INC (MED) is expected to report $1.02 for Q3 2023